Announcement of Jinyao Pharmaceutical Co., Ltd. on the acquisition of the FDA DMF First Medication Letter for difukert APIs

SZSI · Sep 12

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.